GovernAtlasSubmit your product ↗
Discover platforms/Nabla Technologies

GOVERNATLAS / PRODUCT DOSSIER

Nabla

Nabla describes clinical AI for healthcare documentation, dictation and coding workflows. Its posted terms address human review, HIPAA-covered use and an Appendix I BAA; contractual applicability and clinical suitability require separate review.

Explore the product ↗Add to comparison ↗

01 / CONTEXT & SCOPE

Understand the proposition.
Define the boundary.

The decision to make

Decide whether a draft-note workflow fits the clinical review process before evaluating time savings. Specify the encounter types, the record that may be written and who signs off. Keep the PHI-processing contract separate from the clinical decision to rely on an output.

What this record does not establish

The sources establish supplier-described functions and posted contractual provisions. They do not establish clinical accuracy, an executed customer BAA, the applicable regional agreement or the effectiveness of de-identification. Review the training-use language rather than assuming a blanket no-training commitment.

2 current sources · 4 published assertions
Source coverage is a research boundary, not a quality score.

02 / YOUR EVALUATION

Turn interest into a useful trial.

Open the evaluation playbook ↗
A

A test worth running

Use a fictional consultation containing a correction, an uncertain medication history and a statement made by a caregiver. Compare the draft with the scenario, trace how an error is corrected and record who approves the final note. Separately map each service and integration that would receive the recording, transcript or draft.

GovernAtlas editorial proposal. We have not performed this test.

B

Evidence to bring back

  1. Retain the synthetic scenario, draft, corrections and the clinician's review decision.
  2. Identify the governing agreement, service edition and each PHI recipient before a real-data pilot.
  3. Document the de-identified-data terms, customer options and unresolved questions with named owners.

03 / DOCUMENTED EVIDENCE

Read the claim. Inspect the basis.

Each statement retains its classification and preserved source. A vendor assertion is not an independent test result.

01
vendor asserted

Nabla's posted terms require human review of generated outputs and assign customers responsibility for validating appropriateness before clinical use, billing or claims submission. HIPAA-related contract language does not establish output accuracy or clinical safety.

Source, dates & preserved provenanceNabla Technologies — Posted platform terms and HIPAA provisions ↗

Authority: vendor owned
Observed 2026-11-02 · Reviewed 2026-11-02 · current until 2026-12-02

Artifact SHA-256: 4b7b26a2d259c35f8ddedc6e0b44036249138842414c0d2603c7146dc631e655

The hash identifies the preserved capture. The live source may have changed.

02
vendor asserted

Nabla's posted terms permit use of de-identified data for training its internal AI model and discuss disclosure of such data in connection with the services. This is not a no-training promise; de-identification practice and applicability to a particular contract require review.

Source, dates & preserved provenanceNabla Technologies — Posted platform terms and HIPAA provisions ↗

Authority: vendor owned
Observed 2026-11-02 · Reviewed 2026-11-02 · current until 2026-12-02

Artifact SHA-256: 4b7b26a2d259c35f8ddedc6e0b44036249138842414c0d2603c7146dc631e655

The hash identifies the preserved capture. The live source may have changed.

03
vendor asserted

Nabla's posted terms include a HIPAA section requiring covered-entity or business-associate customers using the services with PHI to comply with the Appendix I BAA at account creation. Scope: this posted contractual provision; the applicable regional agreement, service edition and an individual customer's acceptance are not verified.

Source, dates & preserved provenanceNabla Technologies — Posted platform terms and HIPAA provisions ↗

Authority: vendor owned
Observed 2026-11-02 · Reviewed 2026-11-02 · current until 2026-12-02

Artifact SHA-256: 4b7b26a2d259c35f8ddedc6e0b44036249138842414c0d2603c7146dc631e655

The hash identifies the preserved capture. The live source may have changed.

04
vendor asserted

Nabla presents ambient AI, dictation and coding workflows for healthcare documentation. Scope: vendor-described product functions; integration coverage, accuracy and clinical outcomes have not been independently tested by GovernAtlas.

Source, dates & preserved provenanceNabla Technologies — Official product overview ↗

Authority: vendor owned
Observed 2026-11-02 · Reviewed 2026-11-02 · current until 2026-12-02

Artifact SHA-256: 2ce9c140473629e467c7f4d84f839a834aab35140d4455670d6080881df589f9

The hash identifies the preserved capture. The live source may have changed.

Source register

Nabla Technologies — Official product overview ↗vendor owned · captured 2026-11-02
Brand asset provenance

Organization identity asset from its official website; inclusion does not imply endorsement.

Official website ↗ · Original asset ↗

04 / BEFORE YOU COMMIT

Better questions.
A clearer decision.

Resolve these with the provider and your own evaluation team.

01

Which service, plan, region and integrations does the proposed BAA cover?

02

What retention, deletion and model-training terms apply to our exact workflow?

03

Who validates outputs and owns the clinical or operational decision?

Regulatory applicability requires a separate, current determination. Inclusion is not certification.

COMPLIANCE / CLAIMS, SCOPE & GAPS

Start with the requirement.
Inspect the support.

Prepare your vendor review ↗

These labels describe this dossier’s current evidence coverage. A published mention may be a framework mapping, a qualified assertion or a limitation; it is not a compliance finding.

HIPAA

Published mention available

US healthcare privacy & security

Vendor documents BAA availability

Posted terms include an Appendix I BAA for HIPAA-covered use. They also discuss de-identified data use and require human review of outputs; confirm the applicable regional agreement.

Read the source-attributed statement

Nabla's posted terms require human review of generated outputs and assign customers responsibility for validating appropriateness before clinical use, billing or claims submission. HIPAA-related contract language does not establish output accuracy or clinical safety.

vendor asserted

Nabla Technologies — Posted platform terms and HIPAA provisions ↗
Read the source-attributed statement

Nabla's posted terms include a HIPAA section requiring covered-entity or business-associate customers using the services with PHI to comply with the Appendix I BAA at account creation. Scope: this posted contractual provision; the applicable regional agreement, service edition and an individual customer's acceptance are not verified.

vendor asserted

Nabla Technologies — Posted platform terms and HIPAA provisions ↗

Explore HIPAA evidence ↗

For HIPAA-regulated use, request service-specific BAA eligibility, processing scope and responsibility details. Missing evidence here does not establish noncompliance. Payment cannot alter these evidence labels.

KEEP THE RECORD USEFUL

A dossier should stand up to scrutiny.

Have a source that changes this picture? Submit it for editorial review.

Raise an evidence issue ↗